소아 비만 관리 시장 규모, 점유율 및 성장 분석 : 치료 유형별, 생활습관 및 행동 관리별, 약물 요법별, 최종사용자별, 연령층별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Pediatric Obesity Management Market size was valued at USD 3.9 Billion in 2024 and is poised to grow from USD 4.25 Billion in 2025 to USD 8.54 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The rising prevalence of childhood obesity, coupled with heightened awareness of associated health risks, is significantly boosting the pediatric obesity management market. The integration of digital health solutions, access to weight management therapies, and supportive government initiatives are enhancing the effectiveness of obesity interventions. Growing incidences of diabetes, cardiovascular issues, and metabolic disorders emphasize the need for comprehensive weight management programs. The adoption of digital technologies and personalized nutrition strategies is improving patient engagement and treatment outcomes. Additionally, expanded insurance coverage for obesity management and innovative school-based wellness initiatives are creating new market opportunities. However, challenges such as high treatment costs, limited adherence, social stigma, and concerns over the safety of pharmacological treatments may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Obesity Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Obesity Management Market Segments Analysis

Global pediatric obesity management market is segmented by treatment type, lifestyle & behavioral management, pharmacological therapy, end user, age group, distribution channel, and region. Based on treatment type, the market is segmented into lifestyle & behavioral management, nutritional therapy, pharmacological therapy, bariatric surgery, and others. Based on lifestyle & behavioral management, the market is segmented into physical activity programs, behavioral counseling, family-based weight management programs, and others. Based on pharmacological therapy, the market is segmented into GLP-1 Receptor Agonists, Lipase Inhibitors, combination anti-obesity drugs, and others. Based on end user, the market is segmented into hospitals, pediatric clinics, specialty obesity centers, homecare settings, and others. Based on age group, the market is segmented into children (6-12 years), adolescents (13-18 years), and others. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Pediatric Obesity Management Market

Rising public understanding of the long-term consequences of pediatric obesity is driving increased interest in both preventive and therapeutic solutions among parents, educational institutions, and healthcare professionals. This growing awareness is spurring a demand for targeted management programs and products, which will subsequently stimulate market activity. As the emphasis on early screening and consumer education regarding healthy lifestyle choices without relying on medication intensifies, stakeholders-including policymakers, insurers, and technology innovators-will collaborate more effectively. This collaborative environment is expected to foster new opportunities within the pediatric obesity management space, ultimately contributing to more comprehensive solutions for this pressing issue.

Restraints in the Global Pediatric Obesity Management Market

A significant limitation in the Global Pediatric Obesity Management market is the inadequate insurance coverage for various obesity intervention programs. This shortfall leads to low participation rates in weight management initiatives, as patients frequently bear the financial burden of treatment expenses themselves. With insurance premiums, copayments, and costs for necessary home equipment contributing to out-of-pocket expenses, families may find it challenging to commit to long-term treatment options. As many services exceed their covered limits, the high costs associated with ongoing therapies often deter patients from pursuing effective solutions, which is likely to hinder growth within the pediatric obesity management sector.

Market Trends of the Global Pediatric Obesity Management Market

The Global Pediatric Obesity Management market is experiencing a significant trend towards the integration of digital therapeutics. Clinicians are increasingly leveraging advanced digital platforms, including smartphone applications, biosensor technology, and artificial intelligence coaching, to optimize treatment for youth suffering from obesity. This shift allows for enhanced virtual monitoring and communication, enabling continuous patient engagement and swift intervention adjustments without the need for in-person visits. Furthermore, the seamless integration with electronic medical record systems facilitates real-time tracking of patient progress and the rapid adaptation of treatment plans. As these technologies prove effective and scalable, their prominence in pediatric obesity management is expected to expand, transforming how healthcare professionals address this growing concern.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pediatric Obesity Management Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Lifestyle & Behavioral Management
• Nutritional Therapy
• Pharmacological Therapy
• Bariatric Surgery
• Others

Global Pediatric Obesity Management Market Size by Lifestyle & Behavioral Management & CAGR (2026-2033)

• Market Overview
• Physical Activity Programs
• Behavioral Counseling
• Family-Based Weight Management Programs
• Others

Global Pediatric Obesity Management Market Size by Pharmacological Therapy & CAGR (2026-2033)

• Market Overview
• GLP-1 Receptor Agonists
• Lipase Inhibitors
• Combination Anti-Obesity Drugs
• Others

Global Pediatric Obesity Management Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Pediatric Clinics
• Specialty Obesity Centers
• Homecare Settings
• Others

Global Pediatric Obesity Management Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Children (6-12 Years)
• Adolescents (13-18 Years)
• Others

Global Pediatric Obesity Management Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Pediatric Obesity Management Market Size & CAGR (2026-2033)

• North America (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Lifestyle & Behavioral Management, Pharmacological Therapy, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rhythm Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Currax Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WW International (WeightWatchers)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hims & Hers Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Noom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cigna Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UnitedHealth Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations